Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 174

1.

Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).

Cooper C, Bardin T, Brandi ML, Cacoub P, Caminis J, Civitelli R, Cutolo M, Dere W, Devogelaer JP, Diez-Perez A, Einhorn TA, Emonts P, Ethgen O, Kanis JA, Kaufman JM, Kvien TK, Lems WF, McCloskey E, Miossec P, Reiter S, Ringe J, Rizzoli R, Saag K, Reginster JY.

Aging Clin Exp Res. 2016 Feb;28(1):1-16. doi: 10.1007/s40520-015-0522-1. Epub 2016 Jan 8.

PMID:
26746234
2.

Bone material strength is associated with areal BMD but not with prevalent fractures in older women.

Rudäng R, Zoulakis M, Sundh D, Brisby H, Diez-Perez A, Johansson L, Mellström D, Darelid A, Lorentzon M.

Osteoporos Int. 2015 Dec 2. [Epub ahead of print]

PMID:
26630975
3.

Obesity and the relative risk of replacement surgery in knee osteoarthritis patients: A prospective cohort study.

Leyland KM, Judge A, Javaid MK, Diez-Perez A, Carr A, Cooper C, Arden NK, Prieto-Alhambra D.

Arthritis Rheumatol. 2015 Nov 10. doi: 10.1002/art.39486. [Epub ahead of print]

PMID:
26556722
4.

MiRNA profiling of whole trabecular bone: identification of osteoporosis-related changes in MiRNAs in human hip bones.

De-Ugarte L, Yoskovitz G, Balcells S, Güerri-Fernández R, Martinez-Diaz S, Mellibovsky L, Urreizti R, Nogués X, Grinberg D, García-Giralt N, Díez-Pérez A.

BMC Med Genomics. 2015 Nov 10;8:75. doi: 10.1186/s12920-015-0149-2.

5.

Fracture experience among participants from the FROCAT study: what thresholding is appropriate using the FRAX tool?

Azagra R, Zwart M, Aguyé A, Martín-Sánchez JC, Casado E, Díaz-Herrera MA, Moriña D, Cooper C, Díez-Pérez A, Dennison EM; GROIMAP and FROCAT Study Group.

Maturitas. 2016 Jan;83:65-71. doi: 10.1016/j.maturitas.2015.10.002. Epub 2015 Oct 21.

PMID:
26546077
6.

Circulating sclerostin and estradiol levels are associated with inadequate response to bisphosphonates in postmenopausal women with osteoporosis.

Morales-Santana S, Díez-Pérez A, Olmos JM, Nogués X, Sosa M, Díaz-Curiel M, Pérez-Castrillón JL, Pérez-Cano R, Torrijos A, Jodar E, Rio LD, Caeiro-Rey JR, Reyes-García R, García-Fontana B, González-Macías J, Muñoz-Torres M.

Maturitas. 2015 Dec;82(4):402-10. doi: 10.1016/j.maturitas.2015.08.007. Epub 2015 Aug 20.

PMID:
26358930
7.

Parathyroid Hormone-Related Protein Analogs as Osteoporosis Therapies.

Esbrit P, Herrera S, Portal-Núñez S, Nogués X, Díez-Pérez A.

Calcif Tissue Int. 2015 Aug 11. [Epub ahead of print]

PMID:
26259869
8.

Early (1-year) Discontinuation of Different Anti-osteoporosis Medications Compared: A Population-Based Cohort Study.

Carbonell-Abella C, Pages-Castella A, Javaid MK, Nogues X, Farmer AJ, Cooper C, Diez-Perez A, Prieto-Alhambra D.

Calcif Tissue Int. 2015 Dec;97(6):535-41. doi: 10.1007/s00223-015-0040-3. Epub 2015 Jul 23.

PMID:
26202819
9.

Incidence and Predictors of Multiple Fractures Despite High Adherence to Oral Bisphosphonates: A Binational Population-Based Cohort Study.

Hawley S, Javaid MK, Rubin KH, Judge A, Arden NK, Vestergaard P, Eastell R, Diez-Perez A, Cooper C, Abrahamsen B, Prieto-Alhambra D.

J Bone Miner Res. 2016 Jan;31(1):234-44. doi: 10.1002/jbmr.2595.

PMID:
26174968
10.

CYP11A1 expression in bone is associated with aromatase inhibitor-related bone loss.

Rodríguez-Sanz M, García-Giralt N, Prieto-Alhambra D, Servitja S, Balcells S, Pecorelli R, Díez-Pérez A, Grinberg D, Tusquets I, Nogués X.

J Mol Endocrinol. 2015 Aug;55(1):69-79. doi: 10.1530/JME-15-0079. Epub 2015 Jun 24.

PMID:
26108486
11.

Are the High Hip Fracture Rates Among Norwegian Women Explained by Impaired Bone Material Properties?

Duarte Sosa D, Vilaplana L, Güerri R, Nogués X, Wang-Fagerland M, Diez-Perez A, F Eriksen E.

J Bone Miner Res. 2015 Oct;30(10):1784-9. doi: 10.1002/jbmr.2537. Epub 2015 May 21.

PMID:
25900016
12.

Socio-economic status and the risk of developing hand, hip or knee osteoarthritis: a region-wide ecological study.

Reyes C, Garcia-Gil M, Elorza JM, Mendez-Boo L, Hermosilla E, Javaid MK, Cooper C, Diez-Perez A, Arden NK, Bolibar B, Ramos R, Prieto-Alhambra D.

Osteoarthritis Cartilage. 2015 Aug;23(8):1323-9. doi: 10.1016/j.joca.2015.03.020. Epub 2015 Mar 26.

PMID:
25819582
13.

Switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: changes in bone turnover markers and circulating sclerostin levels.

Negredo E, Diez-Pérez A, Bonjoch A, Domingo P, Pérez-Álvarez N, Gutierrez M, Mateo G, Puig J, Echeverría P, Escrig R, Clotet B.

J Antimicrob Chemother. 2015 Jul;70(7):2104-7. doi: 10.1093/jac/dkv063. Epub 2015 Mar 13.

PMID:
25769303
14.

Bone Tissue Properties Measurement by Reference Point Indentation in Glucocorticoid-Induced Osteoporosis.

Mellibovsky L, Prieto-Alhambra D, Mellibovsky F, Güerri-Fernández R, Nogués X, Randall C, Hansma PK, Díez-Perez A.

J Bone Miner Res. 2015 Sep;30(9):1651-6. doi: 10.1002/jbmr.2497. Epub 2015 Jun 11.

PMID:
25736591
15.

Osteoporotic fracture rate among women with at least 1 year of adherence to osteoporosis treatment.

Modi A, Tang J, Sen S, Díez-Pérez A.

Curr Med Res Opin. 2015 Apr;31(4):767-77. doi: 10.1185/03007995.2015.1016606.

PMID:
25708648
16.

Increased hip fracture and mortality in chronic kidney disease individuals: the importance of competing risks.

Pérez-Sáez MJ, Prieto-Alhambra D, Barrios C, Crespo M, Redondo D, Nogués X, Díez-Pérez A, Pascual J.

Bone. 2015 Apr;73:154-9. doi: 10.1016/j.bone.2014.12.020. Epub 2014 Dec 27.

PMID:
25549867
17.

Socioeconomic status and its association with the risk of developing hip fractures: a region-wide ecological study.

Reyes C, García-Gil M, Elorza JM, Fina-Avilés F, Mendez-Boo L, Hermosilla E, Coma E, Carbonell C, Medina-Peralta M, Ramos R, Bolibar B, Díez-Pérez A, Prieto-Alhambra D.

Bone. 2015 Apr;73:127-31. doi: 10.1016/j.bone.2014.12.019. Epub 2014 Dec 24.

PMID:
25542156
18.

Incident type 2 diabetes and hip fracture risk: a population-based matched cohort study.

Martinez-Laguna D, Tebe C, Javaid MK, Nogues X, Arden NK, Cooper C, Diez-Perez A, Prieto-Alhambra D.

Osteoporos Int. 2015 Feb;26(2):827-33. doi: 10.1007/s00198-014-2986-9. Epub 2014 Dec 9.

PMID:
25488807
19.

Current and future treatments of secondary osteoporosis.

Soriano R, Herrera S, Nogués X, Diez-Perez A.

Best Pract Res Clin Endocrinol Metab. 2014 Dec;28(6):885-94. doi: 10.1016/j.beem.2014.09.004. Epub 2014 Sep 16. Review.

PMID:
25432359
20.

Ankylosing spondylitis confers substantially increased risk of clinical spine fractures: a nationwide case-control study.

Prieto-Alhambra D, Muñoz-Ortego J, De Vries F, Vosse D, Arden NK, Bowness P, Cooper C, Diez-Perez A, Vestergaard P.

Osteoporos Int. 2015 Jan;26(1):85-91. doi: 10.1007/s00198-014-2939-3. Epub 2014 Oct 24.

PMID:
25341971
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk